Roselabs Finance Ltd

Roselabs Finance Limited, the micro-cap non-banking financial company under the Lodha Group umbrella, reported a quarterly net loss of ₹0.04 crores for Q3 FY26 (October-December 2025), marking a marginal improvement from the ₹0.06 crore loss in Q2 FY26. With a market capitalisation of just ₹27.00 crores and a deeply negative book value of ₹-4.73 per share, the company remains entrenched in severe financial distress despite sporadic revenue generation.

Roselabs Finance Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Oct 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.

Roselabs Finance has reached a new 52-week low of Rs.19.86, marking a significant decline in its share price amid a broader market environment where the Sensex trades near its yearly highs. The stock’s performance contrasts sharply with the overall market trend, reflecting ongoing concerns within the Non Banking Financial Company (NBFC) sector.

Roselabs Finance, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key analytical parameters, signalling a cautious stance among market observers.

Roselabs Finance has reached a fresh 52-week low of Rs.20.9 today, marking a significant milestone in its recent price trajectory. The stock has experienced a sustained decline over the past several sessions, reflecting ongoing pressures within the Non Banking Financial Company (NBFC) sector and company-specific factors.

Roselabs Finance Ltd has encountered significant selling pressure, with the stock hitting a fresh 52-week low of Rs 20.9 and registering a day decline of 5.00%, markedly underperforming the Sensex which showed a marginal gain of 0.08%. The absence of buyers and a narrow trading range underscore a distress selling scenario, reflecting ongoing investor concerns in the Non Banking Financial Company (NBFC) sector.

Roselabs Finance Ltd is currently experiencing severe selling pressure, with the stock registering a sharp decline and no buying interest visible in the market. The company’s shares have fallen for three consecutive sessions, reflecting distress selling signals and a challenging environment for this Non Banking Financial Company (NBFC).

Roselabs Finance Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the Non Banking Financial Company (NBFC), as the stock continues to trade below all key moving averages amid sustained losses over multiple timeframes.

Roselabs Finance Ltd is currently experiencing severe selling pressure, with the stock registering no buying interest and remaining at a lower circuit. This distress selling signals a challenging phase for the Non Banking Financial Company (NBFC), as it continues to underperform against broader market indices over multiple time frames.

Roselabs Finance Ltd is currently experiencing extreme selling pressure, with the stock registering a day of exclusive sell orders and no buying interest. This development highlights distress selling signals as the company continues to underperform against key market benchmarks over multiple time frames.

Roselabs Finance Ltd has encountered significant selling pressure, with the stock registering only sell orders throughout the trading session. This extreme selling activity signals distress among investors, as the company continues to experience consecutive losses over multiple time frames, underperforming both its sector and the broader market indices.

Roselabs Finance Ltd is currently experiencing extreme selling pressure, with the stock registering only sell orders and no buyers in the queue. This distress selling signals a challenging phase for the Non Banking Financial Company (NBFC), as it continues to face consecutive losses and a sustained downtrend across multiple time frames.

Roselabs Finance has reached a new 52-week low of Rs.21.24, marking a significant decline in its stock price amid a challenging market environment. The stock's performance over the past year reflects persistent pressures, with key financial indicators highlighting ongoing concerns for the company within the Non Banking Financial Company (NBFC) sector.

Roselabs Finance, a Non Banking Financial Company (NBFC), has touched a fresh 52-week low of Rs.22.33 on 19 Nov 2025, marking a significant decline amid ongoing downward momentum in its share price.

Roselabs Finance, a Non Banking Financial Company (NBFC), has reached a new 52-week low of Rs.23.5 today, reflecting a continued downward trend in its stock price amid broader market fluctuations and sector-specific pressures.

Roselabs Finance Ltd is experiencing notable selling pressure, with the stock showing consistent losses. It has declined significantly over the past week and month, hitting a new 52-week low. The stock's performance is weak compared to the Sensex, reflecting broader market trends and company-specific challenges.

Roselabs Finance, a microcap in the NBFC sector, has hit a new 52-week low of Rs. 23.95, reflecting a significant downturn. The stock has underperformed its sector and has experienced a notable decline over the past year, raising concerns about its financial health and future prospects.